Home » FDA Looks for Stakeholder Input on Trials Meant to Assess Abuse of Opioids
FDA Looks for Stakeholder Input on Trials Meant to Assess Abuse of Opioids
The FDA has experienced no shortage of criticism in recent years about its regulation of opioid-based painkillers in light of the drugs’ contribution to what the Centers for Disease Control and Prevention calls an “epidemic of prescription painkiller abuse.”
Regulatory Focus
Regulatory Focus
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May